ClinicalTrials.gg
AvailableNCT06808568EAPSTIMVGUpdated Nov 6, 2026

Expanded Access Program (EAP) STIMULAN VG

An expanded access record providing STIMULAN VG in Stage IV Pressure Ulcer and Diabetic Foot Osteomyelitis, sponsored by Biocomposites Ltd. Available. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-11-06.

Sponsored by Biocomposites Ltd · Expanded access

Study type
Expanded access
Access type
Individual patients
Ages
18 Years and older
Sex
All
01

Study summary

Individual (single) patient expanded access may be considered.

Read the detailed description

Patients facing serious or life-threatening illnesses who have exhausted currently available treatment options and are ineligible or unable to participate in a clinical trial may decide to explore therapeutic use of investigational drugs with their healthcare providers.

Under these circumstances, single-patient access can be requested from a licensed treating physician on behalf of the patient.

Please contact expandedaccess@biocomposites.com for more information.

02

Conditions studied

  • Stage IV Pressure Ulcer
  • Diabetic Foot Osteomyelitis

Browse trials for

03

In context

Pressure Ulcer

545 studies on the registry are indexed under Pressure Ulcer; 129 are open to participants now.

Browse Pressure Ulcer studies →

Lead sponsor

Biocomposites Ltd is the lead sponsor of 4 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

-

Exclusion criteria

Exclusion Criteria:

-

05

Access details

Study type
Expanded access
Access type
Individual patients

Available treatment

  • Combination productSTIMULAN VG
06

Where to request access

No study locations are listed for this record.

07

Updates

1 registry update since Sep 25, 2026
Minor edits
Nothing that changes what the study is or who can join. Edited: verification date, criteria formatting and index terms
1 update, last Nov 6, 2026
Show all 1 update
  1. Nov 6, 2026
    Minor edits only
    + 3 other changes: verification date, criteria formatting and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

08

Registry details

Key details

Study ID
NCT06808568
Lead sponsor
Biocomposites Ltd
Responsible party
Sponsor
First posted
Feb 5, 2025
Last update
Nov 6, 2026

Study contacts

Biocomposites Expanded Access Team
Contact
expandedaccess@biocomposites.com
+44 (0) 1782 338 580
View the source record on ClinicalTrials.gov ↗

Requesting access

Expanded access is arranged between your doctor and the company. Ask your care team to contact the provider listed on this record.

Contact the provider

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion